Adding traditional and emerging biomarkers for risk assessment in secondary prevention: a prospective cohort study of 20 656 patients with cardiovascular disease
Adding several biomarkers, most notably Cystatin C and HbA1c, but not LP-a, in a model using SMART2 predictors modestly improved discrimination.
Authors
- Paul I. Welsh (ORCID: https://orcid.org/0000-0002-7970-3643)
- Patrick Barry Mark (ORCID: https://orcid.org/0000-0003-3387-2123)
- Jill P. Pell (ORCID: https://orcid.org/0000-0002-8898-7035)
- Salil V. Deo (ORCID: https://orcid.org/0000-0002-4729-1461)
- Ike Dhiah Rochmawati (ORCID: https://orcid.org/0000-0002-2497-7399)
- Jennifer Susan Lees (ORCID: https://orcid.org/0000-0001-6331-0178)
- Carlos Celis‐Morales (ORCID: https://orcid.org/0000-0003-2612-3917)
- Naveed A. Sattar (ORCID: https://orcid.org/0000-0002-1604-2593)
- Frederick K. Ho (ORCID: https://orcid.org/0000-0001-7190-9025)
Institutions
- University of Surabaya (ID)
- Catholic University of the Maule (CL)
- Louis Stokes Cleveland VA Medical Center (US)
- University of Glasgow (GB)
- Arturo Prat University (CL)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1093/eurjpc/zwae352
- Citations
- 6
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 3.44
Funders
- Lembaga Pengelola Dana Pendidikan
- Kementerian Keuangan Republik Indonesia